Moscow Clinical Scientific Center

Moscow 111123

0 studies enrolling now · 4 studies all time

What they study most

Crohn's Disease, Relapsed and/or Refractory Multiple Myeloma, Ulcerative Colitis

Studies at this site

• A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) — Completed
• A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma — Completed
• An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis — Completed
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis — Stopped early